SUSCEPTIBILITY OF ANAEROBIC-BACTERIA TO FCE-22101

被引：18

作者：

NORD, CE ^{[1
]}

LINDMARK, A ^{[1
]}

PERSON, I ^{[1
]}

机构：

[1] NATL BACTERIOL LAB,S-10521 STOCKHOLM,SWEDEN

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1987年 / 31卷 / 05期

关键词：

D O I：

10.1128/AAC.31.5.831

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：831 / 833

页数：3

共 50 条

[21] SUSCEPTIBILITY TESTING OF ANAEROBIC-BACTERIA
FINEGOLD, SM
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (07) : 1253 - 1256
[22] SUSCEPTIBILITY TESTING OF ANAEROBIC-BACTERIA
FINEGOLD, SM
ROLFE, RD
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1983, 1 (01) : 33 - 40
[23] ANTIBIOTIC SUSCEPTIBILITY OF ANAEROBIC-BACTERIA
DUBREUIL, L
MEDECINE ET MALADIES INFECTIEUSES, 1990, 20 : 101 - 106
[24] SUSCEPTIBILITY OF ANAEROBIC-BACTERIA TO CEFOXITIN
TRABULSI, LR
REVISTA DE MICROBIOLOGIA, 1979, 10 (02): : 66 - 68
[25] SUSCEPTIBILITY OF ANAEROBIC-BACTERIA TO TOSUFLOXACIN
NORD, CE
LINDMARK, A
PERSSON, I
RUNOW, C
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (03) : 263 - 265
[26] PHARMACOKINETICS OF FCE-22101 IN MAN FOLLOWING DIFFERENT MODES OF ADMINISTRATION
LOVERING, AM
WHITE, LO
LEWIS, DA
MACGOWAN, AP
ROUTH, KR
PICKIN, DM
REEVES, DS
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 : 179 - 195
[27] RAPID HYDROLYSIS INVIVO IN MAN OF FCE-22891, THE ORALLY ABSORBED ESTER OF FCE-22101
VINCON, G
ALBIN, H
BATTAGLIA, R
MIGNON, A
BENEDETTI, MS
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (03) : 486 - 488
[28] INVITRO ACTIVITY OF FCE-22101 AND SYNERGY STUDIES WITH OTHER ANTIMICROBIAL AGENTS
CHIN, NX
NEU, HC
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 : 95 - 101
[29] URINARY METABOLITES OF C-14-LABELED FCE-22101 IN ANIMALS
BENEDETTI, MS
BATTAGLIA, R
VICARIO, G
RONCUCCI, R
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 : 173 - 177
[30] INTERACTIONS OF FCE-22101 WITH CLASS-I BETA-LACTAMASES
YANG, Y
LIVERMORE, DM
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 : 85 - 94

← 1 2 3 4 5 →